Trending Topic

Motor neuron synapses with muscle fiber via electrical impulse transmission and neurotransmitter release, forming neuromuscular junctions , motor neuron, neuroscience
15 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of upper and lower motor neurons that results in progressive motor impairment. ALS is the most common disease of motor neurons with an annual incidence of approximately 1.7–2.5 per 100,000 people. It is a terminal condition with a typical life expectancy of 2–5 years from symptom onset. […]

Search Results

Showing Results for stroke treatment

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

As a touchNEUROLOGY Future Leader 2025, Dr Antonio Ciacciarelli shares what drew him to neurology, the lasting impact of mentorship, and why recent advances in stroke care are redefining outcomes. He reflects on the privilege of inspiring others, and the promise of neuroprotection as the next frontier in vascular neurology.

Mark CompleteCompleted
BookmarkBookmarked

Emerging data at EAN 2025 reveals key innovations across multiple neurological disease areas.

In this article, you will learn:

  1. Biomarkers are transforming dementia diagnosis with earlier and more accurate detection.
  2. CGRP-targeted therapies are advancing personalized migraine care.
  3. Wearables and digital tools are enhancing movement disorder monitoring.
  4. Data-driven decisions are improving stroke management and outcomes.
  5. Gene and molecular therapies are revolutionizing neuromuscular disease treatment.

Mark CompleteCompleted
BookmarkBookmarked
Coverage from: EAN 2025
Simona Sacco

Despite advances in targeted therapies, migraine remains a significant clinical burden.

In this Q&A, you will learn:

  1. How anti-CGRP therapies target migraine-specific pathways to deliver better efficacy and tolerability than traditional treatments.
  2. What real-world data reveal about patient response rates and rare but emerging side effects like Raynaud’s phenomenon.
  3. Why multiple delivery methods, such as oral, subcutaneous, and intravenous, enable higher adherence and more personalized migraine care.

Mark CompleteCompleted
BookmarkBookmarked

Prof. Simona Sacco outlines the European Stroke Organisation’s (ESO) strategic priorities to reduce disparities in stroke care across Europe. She discusses the transformative impact of the ESO East programme and the Stroke Action Plan for Europe (SAP-E), and also reflects on the increasing role of artificial intelligence (AI) in stroke diagnostics and treatment pathways.

Mark CompleteCompleted
BookmarkBookmarked

"My mission is to educate and empower the next generation of physicians, neurologists and researchers. Reminding them that, regardless of where they come from, they have the power to make a difference in people’s lives." We are delighted to ...

Mark CompleteCompleted
BookmarkBookmarked

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode of Visionary Voices, Dr Anthony Caggiano, Chief Medical Officer at Cognition Therapeutics, joins us to explore how biomarkers are transforming our understanding of Alzheimer’s disease, from diagnosis and disease progression to drug development and the future of clinical care.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Mark CompleteCompleted
BookmarkBookmarked

Launching today, the world’s first multisector advocacy movement dedicated to stroke - the Global Stroke Action Coalition - has issued an urgent call to action to address growing inequities in stroke. Already a leading cause of death and disability, without intervention, the global burden of stroke is projected to rise by a further 50% over the next 25 years, claiming 100 million lives and costing US$1.6 trillion each year.  

Mark CompleteCompleted
BookmarkBookmarked

The FDA has approved tenecteplase (TNKase) for the treatment of acute ischemic stroke (AIS) in adults, marking the first new stroke-specific thrombolytic approval in nearly three decades. Administered as a single five-second intravenous bolus, tenecteplase allows for faster administration compared to the current standard of care alteplase, which is administered as a bolus-plus-infusion regimen.

Mark CompleteCompleted
BookmarkBookmarked

The prevalence of unruptured intracranial aneurysms (IAs) is approximately 3% of the population, with incidence on the rise due to the increased utilization of neuro-imaging for diverse objectives.1,2 The average risk of rupture for unruptured IA is estimated to vary from 0.3% ...

Mark CompleteCompleted
BookmarkBookmarked

Seizures are one of the most frequent neurological disorders in neonates − the incidence of seizures in infants born at term is 1–3 per 1,000 live births, and is even higher in both preterm and very-low-birth-weight infants at 1–13 per 1,000 live births.1 Seizures may ...

Mark CompleteCompleted
BookmarkBookmarked

Welcome to this issue of touchREVIEWS in Neurology, where we explore significant advances in neurology, cognitive health, and wearable technology in the management of various chronic conditions. This issue brings together a collection of expert perspectives and research that spans ...

Mark CompleteCompleted
BookmarkBookmarked

Article highlights Multiple screening tests are available to screen patients for cognitive impairment, and the Confusion Assessment Method is a helpful test to screen for delirium in the immediate postoperative period. Medicine reconciliation and identification and removal of potentially inappropriate ...

Mark CompleteCompleted
BookmarkBookmarked
Aleš Tomek, Melinda B Roaldsen, Francesca Romana Pezzella

What is the Stroke Action Plan for Europe? Stroke is one of the most enormous burdens to healthcare services.1 Despite our combined efforts, it affects more than one million people annually in Europe. Although we have abundant knowledge regarding stroke ...

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Neurology. We are excited to present a collection of articles that showcase the latest advancements and diverse perspectives in neurological research and treatment. This issue features insightful reviews and editorials from esteemed ...

Mark CompleteCompleted
BookmarkBookmarked

Introduction The term 'stroke' is used to describe an adverse clinical state involving interference of blood circulation to the brain due to obstruction or rupture of blood vessels.1 Stroke was previously categorized into a cardiovascular disorder until the release of ...

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch three experts provide insights on the impact of ICH in patients receiving DOACs, DOAC-ICH reversal agents and optimizing treatment outcomes.

Load More...
Close Popup